1 Min Read
Feb 1 (Reuters) - Prescient Therapeutics Ltd:
* RECEIVED ITS RESEARCH AND DEVELOPMENT TAX INCENTIVE REBATE FOR 2016/2017 FINANCIAL YEAR AMOUNTING TO $1.1 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.